Repetitive Administration of Low-Dose Lipopolysaccharide Improves Repeated Social Defeat Stress-Induced Behavioral Abnormalities and Aberrant Immune Response
Article in Journal of Neuroimmune Pharmacology (July 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Engeletin alleviates depressive‐like behaviours by modulating microglial polarization via the LCN2/CXCL10 signalling pathway
Article in Journal of Cellular and Molecular Medicine (April 2024)
The interaction of lipocalin-2 and astrocytes in neuroinflammation: mechanisms and therapeutic application
Article in Frontiers in Immunology (March 2024)